Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,013.8
-0.9 (-0.03%)

 

  • STI Straits Times Index
    3,013.8
    -0.9 (-0.03%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,600.1
    18.9 (1.19%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,098.3
    -138.5 (-0.47%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,502.0
    -1.5 (-0.04%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,864.3
    -65.8 (-0.23%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,258.7
    -32.1 (-0.51%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,088.5M
  • Value: 1,589.7M
  • Rise: 159
  • Fall: 161
  • Unch: 454

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
FJ Benjamin0.044+0.001
Oceanus^0.043-
HGH0.012-0.002
Sembcorp Marine0.157-
CWX Global0.005+0.001
Thomson Medical0.108+0.002
Arion Ent0.017-0.005
ICP Ltd0.012+0.002
Shen Yao0.004+0.001
Jasper Inv0.005-

World Indices

World Indices
Name Last Change
Nasdaq 12,723.5 -274.3
HSI 29,098.3 -138.5
HSCEI 11,292.2 -33.4
Jakarta 6,258.7 -32.0
Nikkei 225 28,864.3 -65.8
SSE Comp 3,502.0 -1.5
Shanghai A 3,670.8 -1.6
Shanghai B 244.9 -1.1
KOSPI 3,026.3 -17.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

CONTANGO ASSET MANAGEMENT LIMITED CONTANGO ASSET MANAGEMENT LIMITED
Updated on 05 Mar 2021 (End of trading day)
Last (AUD): 0.850 Change: - High: 0.850 Remarks: -
Change (%): - Low: 0.850
Open 0.850 Yesterday's Close 0.85
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) - Cumulative Value
 
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.02449 Trailing EPS (AUD) e -0.01015 NAV (AUD) b 0.2075
PE a - Trailing PE f - Price / NAV b 4.0964
Dividend (AUD) d - Cash In Hand (AUD) g 0.0733 Issued & Paid-up Shares c 47,490,600
Dividend Yield (%) d - Price / Cash In Hand g 11.596 Treasury Shares h -
Beta - 75 Daysi 0.313 R-Squared - 75 Days(%)i 0.47 Market Cap (M) 40.367
Beta - 500 Daysi -0.043 R-Squared - 500 Days (%)i 0.01 Enterprise Value (M) 38.558
Piotroski F Score 3 Exchange Code CGA Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 66.33 Free Float (%) -
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 24 Nov 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 08 Sep 2016.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CONTANGO ASSET MANAGEMENT LIMITED ASX 40.367 - - 4.0964 -
Industry Biotechnology ASX 3,180.022 44.297 36.391 10.2967 1.077
Local Peer CSL LTD ASX 113,106.883 36.064 29.720 10.7034 1.181
Local Peer POLYNOVO LIMITED ASX 1,587.331 - - 72.0721 -
Local Peer MESOBLAST LTD ASX 1,445.266 - - 1.9237 -
Local Peer TELIX PHARMACEUTIC ASX 1,042.343 - - 13.1935 -
Local Peer OPTHEA LIMITED ASX 506.496 - - 2.5632 -
Local Peer IMUGENE LIMITED ASX 456.922 - - 7.2727 -
Local Peer ANTEOTECH LIMITED ASX 337.273 - - 54.5455 -
Local Peer NEXT SCIENCE LTD ASX 236.925 - - 9.6672 -
Local Peer BIONOMICS LTD ASX 240.977 - - 15.0000 -
Local Peer IMMUTEP LTD ASX 201.105 - - - -
Local Peer KAZIA THERAPEUTICS LIMITED ASX 161.994 - - 5.1139 -
Local Peer NEUREN PHARMACEUTICALS LTD ASX 147.010 - - 6.0739 -
Other Local Peers LEAF RESOURCES LTD (ASX), CHIMERIC THERAPEUTICS LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), GENETIC TECHNOLOGIES (ASX), MEMPHASYS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), PATRYS LIMITED (ASX), BIOTRON (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), ADALTA LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), REGENEUS LTD (ASX), RHINOMED LIMITED (ASX), ACTINOGEN MEDICAL LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), NANOLLOSE LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Global Peer AMGEN INC NASDAQ 128,167.671 17.644 17.644 13.6218 2.888
Global Peer GILEAD SCIENCES INC NASDAQ 79,454.186 645.995 645.969 4.3651 4.293
Global Peer ILLUMINA INC NASDAQ 58,303.099 88.877 88.877 12.4208 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 54,017.088 19.920 19.920 6.2183 -
Global Peer MODERNA INC NASDAQ 52,889.571 - - 20.6490 -
Global Peer WUXI BIO HKEx 376,808.425 327.779 261.689 25.2248 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 48,142.965 13.703 13.703 4.3666 -
Global Peer BIOGEN INC NASDAQ 40,151.200 10.036 10.036 3.7523 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 32,638.634 54.091 54.091 2.8013 -
Global Peer BEIGENE HKEx 206,102.804 - - 6.8697 -
Other Global Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SEAGEN INC (NASDAQ), 10X GENOMICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SINO BIOPHARM (HKEx), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), BIO-TECHNE CORP (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), NOVAVAX INC (NASDAQ), ZAI LAB-SB (HKEx), BRIDGEBIO PHARMA INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ACCELERON PHARMA (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), JOINN (HKEx), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), Lonza (SGX), SANA BIOTECHNOLOGY INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), INSMED INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), GENSCRIPT BIO (HKEx), AGIOS PHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), VERACYTE INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), SEER INC (NASDAQ), VIELA BIO INC (NASDAQ), ALKERMES PLC (NASDAQ), NANTKWEST INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), 3SBIO (HKEx), ARCUS BIOSCIENCES INC (NYSE), LIGAND PHARMACEUTICAL INC (NASDAQ), NUVATION BIO INC (NYSE), ALLOVIR INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), KURA ONCOLOGY INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), BLUEBIRD BIO INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), BIOATLA INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), JACOBIO-B (HKEx), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), SHATTUCK LABS INC (NASDAQ), OCUGEN INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), JW THERAP-B (HKEx), IMMUNOGEN INC (NASDAQ), REGENXBIO INC (NASDAQ), PRECIGEN INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), SANGAMO THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), UNIQURE N.V. (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), NKARTA INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ALECTOR INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), FRONTAGE (HKEx), HAOHAI BIOTEC (HKEx), VOR BIOPHARMA INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), VAXCYTE INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ASCENTAGE-B (HKEx), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), JHBP-B (HKEx), MIMEDX GROUP INC (NASDAQ), PERSONALIS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), OMEROS CORP (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PASSAGE BIO INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), INHIBRX INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), KINTOR PHARMA-B (HKEx), KARYOPHARM THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), HUMANIGEN INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), KADMON HLDGS INC (NASDAQ), CHIMERIX INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), CURIS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), VAXART INC (NASDAQ), COMPUGEN (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), IMMATICS N V (NASDAQ), AKOUOS INC (NASDAQ), ATRECA INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), MAGENTA THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), AFFIMED N V (NASDAQ), ARDELYX INC (NASDAQ), AGENUS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), GERON CORP (NASDAQ), IVERIC BIO INC (NASDAQ), XBIOTECH INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), SINOMAB BIO-B (HKEx), JOUNCE THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), ALTIMMUNE INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), DPHARMA (Bursa), SUMMIT THERAPEUTICS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AVROBIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ESSEX BIO-TECH (HKEx), PUMA BIOTECHNOLOGY INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), LEE'S PHARM (HKEx), UROGEN PHARMA LTD (NASDAQ), ADICET BIO INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), ASCLETIS-B (HKEx), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), SESEN BIO INC (NASDAQ), VERASTEM INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), SQZ BIOTECHNOLOGIES CO (NYSE), ATHERSYS INC (NASDAQ), ONCORUS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), TREVENA INC (NASDAQ), IMMUNOME INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), NANOVIRICIDES INC (NYSE American), CHECKMATE PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), KAMADA LTD (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), MEDICINOVA INC (NASDAQ), CABALETTA BIO INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), ONCONOVA THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), METACRINE INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), INMUNE BIO INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), BIOVIE INC (NASDAQ), CHIASMA INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), EQUILLIUM INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), BIOMX INC (NYSE American), EVOGENE LTD (NASDAQ), CEL-SCI CORP (NYSE American), ORGENESIS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CONTRAFECT CORP (NASDAQ), IBIO INC (NYSE American), ENZO BIOCHEM INC (NYSE), LONGEVERON INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), OTONOMY INC (NASDAQ), ARAVIVE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), RECRO PHARMA INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SYNLOGIC INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), SAVARA INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), UNI-BIO GROUP (HKEx), COHBAR INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ADVAXIS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), PULMATRIX INCORPORATED (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), REGENT PACIFIC (HKEx), ACORDA THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), BIOCARDIA INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ATYR PHARMA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), CT ENTERPRISE (HKEx), BIO-PATH HOLDINGS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), ORAGENICS INC (NYSE American), PRECIPIO INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), Suntar Eco-City (SGX), AURIS MEDICAL HOLDING LTD (NASDAQ), HISTOGEN INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), INMED PHARMACEUTICALS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), GEOVAX LABS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), SENESTECH INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), HAO WEN HLDGS (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days ---
20 Days -+0.030
+3.66 %
Medium Term Return 3 Months ---
6 Months -+0.430
+102.38 %
1 Year -+0.450
+112.50 %
Long Term Return 2 Years -+0.410
+93.18 %
3 Years -+0.485
+132.88 %
Annualised Return Annualised --
+32.55 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.250 - 0.900 Change From 1 Year Low +0.600 % Change From 1 Year Low (%) +240.00
Change From 1 Year High -0.050 % Change From 1 Year High (%) -5.56
2 Years Range 0.250 - 0.900 Change From 2 Years Low +0.600 % Change From 2 Years Low (%) +240.00
Change From 2 Years High -0.050 % Change From 2 Years High (%) -5.56
5 Years Range 0.215 - 1.930 Change From 5 Years Low +0.635 % Change From 5 Years Low (%) +295.35
Change From 5 Years High -1.080 % Change From 5 Years High (%) -55.96
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Contango Asset Management Ltd. is a financial services company. It engages in the provision of asset management services. The firm manages ASX ex-30 dividend income strategy, Contango Income Generator Limited, and the large cap global ex-Australia growth strategy, Contango Global Growth Limited. The company was founded on December 21, 1998 and is headquartered in Sydney, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
05 Mar 2021 0.850 0.850 0.850 0.850 - -
04 Mar 2021 0.850 0.850 0.850 0.850 13,512 -
03 Mar 2021 0.850 0.850 0.850 0.850 12,254 -
02 Mar 2021 0.850 0.850 0.850 0.850 - -
01 Mar 2021 0.850 0.850 0.850 0.850 - -
26 Feb 2021 0.850 0.850 0.850 0.850 14,234 -
25 Feb 2021 0.850 0.850 0.850 0.850 - -
24 Feb 2021 0.850 0.850 0.850 0.850 38,919 -
23 Feb 2021 0.850 0.850 0.850 0.850 76,178 -
22 Feb 2021 0.850 0.850 0.850 0.850 - -
19 Feb 2021 0.850 0.850 0.850 0.850 6,000 -
18 Feb 2021 0.850 0.850 0.850 0.850 - -
17 Feb 2021 0.850 0.850 0.850 0.850 43,943 -
16 Feb 2021 0.820 0.820 0.820 0.820 20,282 -
15 Feb 2021 0.820 0.820 0.820 0.820 3,300 -
12 Feb 2021 0.820 0.820 0.820 0.820 - -
11 Feb 2021 0.820 0.820 0.820 0.820 25,000 -
10 Feb 2021 0.850 0.850 0.850 0.850 - -
09 Feb 2021 0.850 0.850 0.850 0.850 2,423 -
08 Feb 2021 0.700 0.820 0.700 0.820 46,507 -
05 Feb 2021 0.820 0.820 0.820 0.820 30,487 -
04 Feb 2021 0.820 0.820 0.820 0.820 - -
Summary
Current 2 Weeks
(22 Feb 2021 to 05 Mar 2021)		 0.850 0.850 0.850 0.850 155,097 -
Previous 2 Weeks
(08 Feb 2021 to 19 Feb 2021)		 0.700 0.850 0.700 0.850 147,455 -
4 Weeks from
(08 Jan 2021 to 05 Feb 2021)		 0.850 0.850 0.850 0.820 60,508 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.